Google AI ModeSep 28, 2026
Terray Therapeutics (EMMI): Terray’s chemistry-first, AI-native platform
Data as of Oct 20, 2026Based on 809 AI responses
Reviewed by Dimitry Apollonsky
AI summary
Terray Therapeutics is a company that develops small-molecule medicines by using its own hardware, datasets, and platforms.
2%
across Terray Therapeutics’s markets · since Jul 5
The market map
Biopharma Research Platforms and ServicesMentioned in
Each engine’s share of its own answers across Terray Therapeutics’s markets · since Jul 5
Where Terray Therapeutics ranks in AI
Question: We need automated lab planning and robotic execution tied to model feedback. What companies are building this?
ChatGPT SearchAug 13, 2026
Terray Therapeutics is doing this specifically for small-molecule drug discovery.
Question: Which AI-native platforms help small biotech teams compete with large pharma research groups?
Google AI ModeSep 20, 2026
Terray Therapeutics (EMMI): A chemistry-first, AI-native small-molecule platform that integrates ultra-large-scale proprietary physical data generation with computation.
terraytx.com 0%Other sites 100%
Excerpts where Terray Therapeutics appeared in the AI's answer
Terray Therapeutics (EMMI): Terray’s chemistry-first, AI-native platform
Terray Therapeutics (EMMI): A chemistry-first, AI-native small-molecule platform that integrates ultra-large-scale proprietary physical data generation with computation.
Excerpts where Terray Therapeutics appeared in the AI's answer
Terray Therapeutics is doing this specifically for small-molecule drug discovery.
Excerpts where Terray Therapeutics appeared in the AI's answer
- **Terray Therapeutics (COATI / EMMI)** : Exceptional for **data-driven binding affinity and potency prediction** .
Terray Therapeutics (COATI / EMMI) : Exceptional for data-driven binding affinity and potency prediction .